Neomorph
Targeting the Undruggable
San Diego, United States · Founded 2020 · $209.0M raised
- Headquarters
- San Diego, California
- Employees
- 51–200
- Founded
- 2020
- Business Model
- B2B
- Website
- neomorph.com
- Total Funding
- $209.0M
- Last Round
- $100.0M Series BApr 2026
- Rounds
- 3
About
Neomorph is a clinical-stage biotech company founded in 2020 and headquartered in San Diego, California, pioneering molecular glue degrader medicines.
Summary
Neomorph is a Biotech company based in San Diego, United States, founded in 2020. It has raised $209.0M in total across 3 rounds, most recently a $100.0M Series B round in Apr 2026. Investors include Deerfield Management, Longwood Fund and Alexandria Venture Investments.
Tech & App Stack
5 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Apr 2026
Sign up to see all 3 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.